Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement

Table 3 Prevalence of anti-CCP antibodies and RF in the serum of patients enrolled in this study

Variable	RA (n = 30)	HCV without articular involvement (n = 31)	HCV with articular involvement (n = 8)
Anti-CCP, no. (%)	23 (76.6)	0 (0)	0 (0)
RF, no. (%)	27 (90)	3 (9.7)	3 (37.5)

Anti-CCP, anti-cyclic citrullinated peptide; HCV, hepatitis C virus; RA, rheumatoid arthritis; RF, rheumatoid factor.

ISSN: 1478-6362